ATE204479T1 - Pharmazeutische und/oder diätische zusammensetzungen mit antioxydationswirkung, welche carnosin und verzweigte aminosäure enthalten - Google Patents

Pharmazeutische und/oder diätische zusammensetzungen mit antioxydationswirkung, welche carnosin und verzweigte aminosäure enthalten

Info

Publication number
ATE204479T1
ATE204479T1 AT96916082T AT96916082T ATE204479T1 AT E204479 T1 ATE204479 T1 AT E204479T1 AT 96916082 T AT96916082 T AT 96916082T AT 96916082 T AT96916082 T AT 96916082T AT E204479 T1 ATE204479 T1 AT E204479T1
Authority
AT
Austria
Prior art keywords
pharmaceutical
amino acid
antioxidant action
branched amino
pct
Prior art date
Application number
AT96916082T
Other languages
English (en)
Inventor
Roberto Bianchi
Original Assignee
Farmila Farma Milano
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmila Farma Milano filed Critical Farmila Farma Milano
Application granted granted Critical
Publication of ATE204479T1 publication Critical patent/ATE204479T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT96916082T 1995-05-19 1996-05-15 Pharmazeutische und/oder diätische zusammensetzungen mit antioxydationswirkung, welche carnosin und verzweigte aminosäure enthalten ATE204479T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI951021A IT1275434B (it) 1995-05-19 1995-05-19 Composizioni farmaceutiche e/o dietetiche ad attivita' antiossidante
PCT/EP1996/002079 WO1996036348A1 (en) 1995-05-19 1996-05-15 Pharmaceutical and/or dietetic compositions with antioxidant activity containing carnosine or derivatives and branched amino acids

Publications (1)

Publication Number Publication Date
ATE204479T1 true ATE204479T1 (de) 2001-09-15

Family

ID=11371632

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96916082T ATE204479T1 (de) 1995-05-19 1996-05-15 Pharmazeutische und/oder diätische zusammensetzungen mit antioxydationswirkung, welche carnosin und verzweigte aminosäure enthalten

Country Status (11)

Country Link
US (1) US5866537A (de)
EP (1) EP0825871B1 (de)
JP (1) JP4850986B2 (de)
AT (1) ATE204479T1 (de)
AU (1) AU697990B2 (de)
CA (1) CA2221455C (de)
DE (1) DE69614681T2 (de)
ES (1) ES2159737T3 (de)
IT (1) IT1275434B (de)
PT (1) PT825871E (de)
WO (1) WO1996036348A1 (de)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2327404A1 (de) * 1994-11-08 2011-06-01 Avicena Group, Inc. Verwendung von Kreatinin und Kreatininanaloga zur Behandlung von Erkrankungen des Nervensystems
IT1283967B1 (it) * 1996-03-29 1998-05-07 Sigma Tau Ind Farmaceuti Uso di l-carnitina o derivati della l-carnitina ed antiossidanti nella prevenzione e trattamento di patologie derivanti da danni ossidativi
US7150880B2 (en) 1996-05-31 2006-12-19 The Original Creatine Patent Co. Ltd. Compositions containing creatine and creatinine and a methyl xanthine
US8128955B2 (en) 1996-05-31 2012-03-06 The Original Creatine Patent Company Food compositions containing creatine
GB9611356D0 (en) * 1996-05-31 1996-08-07 Howard Alan N Improvements in or relating to compositions containing Creatine, and other ergogenic compounds
US6168802B1 (en) 1996-05-31 2001-01-02 The Howard Foundation Compositions containing creatine and aloe vera extract
US6274161B1 (en) 1996-05-31 2001-08-14 The Howard Foundation Compositions containing creatine in suspension
US6524611B2 (en) 1996-05-31 2003-02-25 The Howard Foundation Compositions containing creatine and creatinine
DE19649891C2 (de) * 1996-12-02 1998-12-10 Mk Produktkontor Gmbh Verwendung von antioxidativen Zusammensetzungen mit Süßmolkekonzentrat
AU6141498A (en) * 1997-02-04 1998-08-25 John V. Kosbab Compositions and methods for prevention and treatment of vascular degenerative diseases
RU2141483C1 (ru) * 1997-07-04 1999-11-20 Небольсин Владимир Евгеньевич Производные пептидов или их фармацевтически приемлемые соли, способ их получения, применение и фармацевтическая композиция
DE19806890A1 (de) * 1998-02-19 1999-08-26 Beiersdorf Ag Kosmetische und dermatologische Wirkstoffkombinationen aus mindestens einer Substanz gewählt aus der Gruppe, bestehend aus Carnitin und den Acylcarnitinen, und mindestens einem Antioxidans sowie Zubereitungen mit einem Gehalt an solchen Wirkstoffkombinationen
EP1065931A4 (de) * 1998-04-02 2006-10-11 Avicena Group Inc Eine kombination einer kreatin-verbindung und eines zweiten stoffes enthaltende zusammensetzungen
US20060128671A1 (en) * 1998-04-02 2006-06-15 The General Hospital Corporation Compositions containing a combination of a creatine compound and a second agent
IT1299191B1 (it) * 1998-06-23 2000-02-29 Sigma Tau Healthscience Spa Composizione atta a prevenire e trattare l'osteoporosi e le alterazioni legate alla menopausa
US6149924A (en) * 1998-07-20 2000-11-21 Biomed Research & Technologies, Inc. Composition for enhancing lipid production, barrier function, hydrogen peroxide neutralization, and moisturization of the skin
PT1100589E (pt) 1998-07-30 2005-05-31 Sigma Tau Ind Farmaceuti Utilizacao de propionil-l-carnitina e acetil-l-carnitina na preparacao de medicamentos com actividade anticancerigena
WO2000007607A1 (en) * 1998-08-04 2000-02-17 Kosbab, John, V. Nutrient and therapeutic compositions for the treatment of cancer
IT1302863B1 (it) * 1998-11-13 2000-10-10 Sigma Tau Healthscience Spa Composizione ad attivita' antiossidante e preventiva di alterazionitrombotiche e aterosclerotiche comprendente una carnitina ed un
NO993678L (no) * 1999-07-28 2001-01-29 Norsk Hydro As Fôr for salmonider
US6294579B1 (en) 1999-10-11 2001-09-25 Joseph W. Carnazzo Method for improving delivery of tyrosine supplementation
AUPQ515000A0 (en) * 2000-01-19 2000-02-10 Grigg, Geoffrey Walter Treatment of uv induced immunosuppression
US8753675B1 (en) * 2000-01-20 2014-06-17 Raj K. Chopra Reduced form of Coenzyme Q in high bioavailability stable dosage forms and related applications
US6476010B2 (en) 2000-03-10 2002-11-05 Hill's Pet Nutrition Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and lower animals
IT1317008B1 (it) * 2000-04-04 2003-05-26 Sigma Tau Healthscience Spa Integratore alimentare energizzante sulla muscolatura scheletrica eprotettivo sull'apparato cardiovascolare.
US8252309B2 (en) * 2000-04-04 2012-08-28 Sigma-Tau Industrie Farmaceutiche Riunite Spa Dietary supplement energy-providing to skeletal muscles
ATE365036T1 (de) * 2000-09-14 2007-07-15 Univ Nebraska Creatinester-pronutrient-verbindungen und formulierungen
US20030212136A1 (en) * 2001-09-14 2003-11-13 Vennerstrom Jonathan L. Creatine ester pronutrient compounds and formulations
ATE328596T1 (de) * 2001-03-16 2006-06-15 Suntory Ltd Autonomsystem kontrollagentien und gesundheitsgetränke und -nahrungsmittel
JP2005528424A (ja) * 2002-06-04 2005-09-22 アビセナ グループ インコーポレイティッド 脳内エネルギー代謝を調節することによって認知機能障害を治療する方法
US6793193B2 (en) * 2002-08-20 2004-09-21 Dart Industries Inc. Adjustable mold for forming shaped food
US7795203B2 (en) * 2002-09-30 2010-09-14 Babizhayev Mark A Method for topical treatment of eye disease and composition and device for said treatment
WO2004064866A1 (ja) * 2003-01-20 2004-08-05 Innovative Vision Products, Inc. カルノシナーゼ阻害剤とｌ−カルノシン類との併用および組成物
PL1591105T3 (pl) 2004-03-17 2020-11-30 Stada Arzneimittel Ag Zastosowanie przeciwutleniaczy do wytwarzania kompozycji farmaceutycznej lub kosmetycznej do ochrony skóry przed uszkodzeniem wywołanym przez promieniowanie podczerwone
EP1761272B1 (de) 2004-06-08 2013-04-24 Flamma S.P.A. D-carnosin enthaltende zusammensetzungen
JP2006052186A (ja) * 2004-08-16 2006-02-23 Toagosei Co Ltd 新規ジヒドロフェルラ酸縮合物
WO2006026304A1 (en) * 2004-08-25 2006-03-09 Ivax Corporation Cardioprotective formulations and uses thereof
EP1883406B1 (de) 2005-05-23 2016-07-06 Natural Alternatives International, Inc. Zusammensetzungen und verfahren zur anhaltenden freisetzung von beta-alanin
WO2007133673A2 (en) * 2006-05-11 2007-11-22 Avicena Group, Inc. Methods of treating a neurological disorder with creatine monohydrate
US9421262B2 (en) * 2009-10-28 2016-08-23 Biomed Research & Technologies, Inc. Compositions and methods for treating dermatological conditions
JPWO2011078204A1 (ja) * 2009-12-24 2013-05-09 浜理薬品工業株式会社 高脂血症の予防または治療剤、および抗疲労剤
BR112013016021A2 (pt) * 2010-12-21 2018-12-11 Nestec Sa métodos e composições adequadas para gerenciar glicemia em animais
US9233099B2 (en) 2012-01-11 2016-01-12 University Of Cincinnati Methods of treating cognitive dysfunction by modulating brain energy metabolism
JP2014114244A (ja) * 2012-12-11 2014-06-26 Ito En Ltd 抗疲労剤組成物
JP6401028B2 (ja) * 2014-11-27 2018-10-03 Ｓｈｉｏｄａライフサイエンス株式会社 鯨筋肉抽出物からなる中長期記憶障害予防改善剤
JP2016130229A (ja) * 2015-01-15 2016-07-21 有限会社アント アミノ酸溶解物の製造方法および該製造方法により製造したアミノ酸溶解物
FR3056381B1 (fr) * 2016-09-26 2019-11-15 Futur Optimal Composition comprenant de la carnosine
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
EP3668499A1 (de) 2017-08-14 2020-06-24 Axcella Health Inc. Aminosäurezusammensetzungen zur behandlung von lebererkrankungen
EP3810123A1 (de) 2018-06-20 2021-04-28 Axcella Health Inc. Zusammensetzungen und verfahren zur behandlung von fettinfiltration in muskeln
US20220218640A1 (en) 2021-01-14 2022-07-14 Rob Dickerman Amino acid delivery system
JP2023156812A (ja) * 2022-04-13 2023-10-25 サントリーホールディングス株式会社 組成物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1240336B (it) * 1990-03-21 1993-12-07 Setra Composizioni farmaceutiche,dietetiche o veterinarie ad attivita' eumetabolica

Also Published As

Publication number Publication date
AU697990B2 (en) 1998-10-22
JPH11505540A (ja) 1999-05-21
ITMI951021A1 (it) 1996-11-19
CA2221455C (en) 2008-07-08
ES2159737T3 (es) 2001-10-16
US5866537A (en) 1999-02-02
JP4850986B2 (ja) 2012-01-11
CA2221455A1 (en) 1996-11-21
DE69614681D1 (de) 2001-09-27
AU5897496A (en) 1996-11-29
PT825871E (pt) 2001-12-28
ITMI951021A0 (it) 1995-05-19
EP0825871A1 (de) 1998-03-04
DE69614681T2 (de) 2002-07-04
IT1275434B (it) 1997-08-07
EP0825871B1 (de) 2001-08-22
WO1996036348A1 (en) 1996-11-21

Similar Documents

Publication Publication Date Title
ATE204479T1 (de) Pharmazeutische und/oder diätische zusammensetzungen mit antioxydationswirkung, welche carnosin und verzweigte aminosäure enthalten
FR2688422B1 (de)
AU4114296A (en) Combined preparation for stimulating hair growth and optionally nail growth and skin regeneration and for preventing or combatting hair loss
CA2341973A1 (en) Antioxidant composition comprising acetyl l-carnitine and .alpha.-lipoic acid
EP1166767A3 (de) Hautpflegemittel enthaltend Hydroxyprolin oder N-Acetylhydroxyprolinderivate
FI961809A (fi) Uudet (R)-5-karbamoyyli-8-fluori-3-N,N-disubstituoitu-amino 3,4-dihydro-2H-1-bentsopyraanit
AU1380199A (en) Gelatine compositions
ES2092266T3 (es) Composiciones para la nutricion ingeribles oralmente, que tienen apetibilidad mejorada.
MX9504034A (es) Formas de administracion medicamentosas que contienen acido tioctico, o sales solidas del acido tioctico de liberacion y biodisponibilidad mejoradas.
ATE335462T1 (de) Pharmazeutische und/oder kosmetische zusammensetzungen enthaltend meerwasser
CA2284738A1 (en) Nutritional composition for improvements in cell energetics
HUP9900085A3 (en) Azine derivatives, of amino acids and pharmaceutical compositions containing them
UA35611C2 (uk) Композиція місцевого застосування для інгібування росту волос у ссавців, спосіб із її використанням та композиція місцевого застосування для доставки водорозчинного фармакологічного засобу до шкіри
DE60012301D1 (de) Lipoproteinkomplexe und zusammensetzungen, die diese enthalten
ATE213633T1 (de) Lamotrigin haltiges arzneimittel
PL336530A1 (en) Solid preparations suitable for oral administration, containing l-carnitine or alkanoyl-l-carnitine magnesium fumarate
ATE151636T1 (de) Diphosphonsäuren und deren salze enthaltende arzneimittel
BR9608392A (pt) Preparação multiparticulada de liberação controlada e forma de dosagem em tablete.
KR950010884A (ko) 사람 및 동물에서 염증성 반응을 일으키는 공격 또는 패혈증 치료용의 아미노산계 조성물
ATE383332T1 (de) Alpha-ketoglutarate von wirkstoffen und deren zusammensetzungen
GEP20022751B (en) Aqueous Pharmaceutical Composition Comprising an Active Ingredient Which Is Highly Insoluble in Water
BR0111579A (pt) Sais duplos de ácido fumárico com uma carnitina e um aminoácido e suplementos alimentares, suplementos diéteticos e drogas contendo os mesmos
CA2051260A1 (fr) Systeme anti-oxydant a base d'un acide amine basique en association avec au moins un tocopherol ou un de ses derives et au moins un polypeptide non thiole et compositions contenant un tel systeme anti-oxydant
BG103905A (en) New bpc peptide salts with organoprotective activity, method for their preparation and application in medicine
GB9505082D0 (en) Medicament

Legal Events

Date Code Title Description
EEIH Change in the person of patent owner